U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1774G>A (p.Gly592Arg) AND Familial hypercholesterolemia

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Dec 17, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001178326.9

Allele description [Variation Report for NM_000527.5(LDLR):c.1774G>A (p.Gly592Arg)]

NM_000527.5(LDLR):c.1774G>A (p.Gly592Arg)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1774G>A (p.Gly592Arg)
Other names:
NM_000527.4(LDLR):c.1774G>A
HGVS:
  • NC_000019.10:g.11116927G>A
  • NG_009060.1:g.32547G>A
  • NM_000527.5:c.1774G>AMANE SELECT
  • NM_001195798.2:c.1774G>A
  • NM_001195799.2:c.1651G>A
  • NM_001195800.2:c.1270G>A
  • NM_001195803.2:c.1393G>A
  • NP_000518.1:p.Gly592Arg
  • NP_000518.1:p.Gly592Arg
  • NP_001182727.1:p.Gly592Arg
  • NP_001182728.1:p.Gly551Arg
  • NP_001182729.1:p.Gly424Arg
  • NP_001182732.1:p.Gly465Arg
  • LRG_274t1:c.1774G>A
  • LRG_274:g.32547G>A
  • LRG_274p1:p.Gly592Arg
  • NC_000019.9:g.11227603G>A
  • NM_000527.4:c.1774G>A
Protein change:
G424R
Links:
dbSNP: rs763147599
NCBI 1000 Genomes Browser:
rs763147599
Molecular consequence:
  • NM_000527.5:c.1774G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1774G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1651G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.1270G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.1393G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001342731Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Sep 14, 2022)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV001399560Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 17, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Healthkeeping in the workplace.

Hickey P.

Occup Health Saf. 1979 Oct;48(7):61-3. No abstract available.

PubMed [citation]
PMID:
503411
See all PubMed Citations (15)

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV001342731.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This missense variant (also known as p.Gly571Arg in the mature protein and as p.Gly465Arg based on a different transcript NM_001195803.2) replaces glycine with arginine at codon 592 in the fifth LDLR type B repeat of the LDLR protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in eight individuals affected with familial hypercholesterolemia including one homozygote with premature coronary artery disease (PMID: 27932355, 33732287, 35910211, ClinVar SCV000503411.1, SCV002568019.1). This variant has also been observed in two unaffected individuals (PMID: 27050191, 35910211). This variant has been identified in 4/251478 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Gly592Glu, is known to cause disease (Clinvar variation ID:161271), indicating that glycine at this position is important for the protein function. Based on the available evidence, this variant is classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001399560.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 592 of the LDLR protein (p.Gly592Arg). This variant is present in population databases (rs763147599, gnomAD 0.01%). This missense change has been observed in individual(s) with hypercholesterolemia (PMID: 27932355, 33740630, 35910211). This variant is also known as c.1393G>A (p.Gly465Arg). ClinVar contains an entry for this variant (Variation ID: 373769). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function with a positive predictive value of 95%. This variant disrupts the p.Gly592 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15864114, 20663204, 21310417, 21925044, 23375686, 26238499). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024